Company intelligence / Profile preview
Cellgenic
- Ownership
- Private
- Development stage
- Other
Overview
Cellgenic is a biotechnology company specializing in the development and commercialization of exosome-based products for regenerative medicine and aesthetics. The company leverages advanced isolation technologies to produce high-purity, stem cell-derived exosomes containing bioactive molecules like growth factors and signaling proteins. Their product portfolio primarily targets skin rejuvenation, hair restoration, and orthopedic applications, offering non-invasive alternatives to traditional cell therapies. Cellgenic aims to harness the signaling power of extracellular vesicles to promote tissue repair and modulate inflammatory responses. Based in Florida, the company operates at the intersection of biotechnology and medical aesthetics, focusing on high-concentration formulations for clinical and wellness use.
- Therapeutic areas
- ImmunologyRheumatologyDermatology
- Modalities
- Exosome-based therapyCell therapy
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Cellgenic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellgenic.